• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浸润性膀胱癌的特征:组织学和分子标志物

Characteristics of invasive bladder cancers: histological and molecular markers.

作者信息

Liebert M, Seigne J

机构信息

Department of Urology, University of Texas MD, Anderson Cancer Center, Houston 77030, USA.

出版信息

Semin Urol Oncol. 1996 May;14(2):62-72.

PMID:8734733
Abstract

Changes in gene expression permit the emergence of clones of cancer cells with biological properties that enable invasion and metastasis. We present in this article an overview of the variety of genetic and antigenic markers that have been reported for invasive bladder cancer. Although the prognostic and diagnostic usefulness of many of these markers in invasive bladder cancer remains to be fully evaluated, this review will serve as a resource for the clinician on the current state of the field. Alterations in the biology and genetics of cells no doubt contribute to the processes of invasion and metastasis and are likely to provide important, useful information for future identification and management of the patient with invasive bladder cancer.

摘要

基因表达的变化使得具有侵袭和转移生物学特性的癌细胞克隆得以出现。在本文中,我们概述了已报道的侵袭性膀胱癌的各种遗传和抗原标志物。尽管这些标志物中的许多在侵袭性膀胱癌中的预后和诊断价值仍有待充分评估,但本综述将为临床医生提供该领域当前状况的参考资料。细胞生物学和遗传学的改变无疑促成了侵袭和转移过程,并且可能为未来侵袭性膀胱癌患者的识别和管理提供重要且有用的信息。

相似文献

1
Characteristics of invasive bladder cancers: histological and molecular markers.浸润性膀胱癌的特征:组织学和分子标志物
Semin Urol Oncol. 1996 May;14(2):62-72.
2
The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.p53肿瘤抑制基因与核蛋白:基础科学综述及其在膀胱癌治疗中的相关性
J Urol. 2003 Apr;169(4):1219-28. doi: 10.1097/01.ju.0000056085.58221.80.
3
Molecular genetics of bladder cancer: targets for diagnosis and therapy.膀胱癌的分子遗传学:诊断与治疗靶点
J Exp Clin Cancer Res. 2006 Jun;25(2):145-60.
4
Alterations of tumor suppressor genes in bladder cancer.膀胱癌中肿瘤抑制基因的改变。
Semin Diagn Pathol. 1997 May;14(2):123-32.
5
[Non-invasive molecular detection of bladder cancer].[膀胱癌的非侵入性分子检测]
Harefuah. 2009 Jan;148(1):66-9, 86.
6
Bladder cancer.膀胱癌
Curr Opin Oncol. 1998 May;10(3):273-8.
7
Molecular markers for detection, surveillance and prognostication of bladder cancer.用于膀胱癌检测、监测和预后评估的分子标志物。
Int J Urol. 2009 Mar;16(3):234-43. doi: 10.1111/j.1442-2042.2008.02225.x.
8
Tumor suppressor gene alterations in bladder carcinoma. Translational correlates to clinical practice.
Surg Oncol Clin N Am. 1995 Apr;4(2):231-40.
9
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.浸润性膀胱癌的分子通路:对机制、进展及靶点识别的新见解
J Clin Oncol. 2006 Dec 10;24(35):5552-64. doi: 10.1200/JCO.2006.08.2073.
10
[Molecular biology studies of bladder cancer].[膀胱癌的分子生物学研究]
Urologe A. 1991 May;30(3):167-71.

引用本文的文献

1
Tumor heterogeneity in muscle-invasive bladder cancer.肌层浸润性膀胱癌中的肿瘤异质性
Transl Androl Urol. 2020 Dec;9(6):2866-2880. doi: 10.21037/tau.2020.03.13.
2
POFUT1 mRNA expression as an independent prognostic parameter in muscle-invasive bladder cancer.POFUT1信使核糖核酸表达作为肌层浸润性膀胱癌的一个独立预后参数。
Transl Oncol. 2021 Jan;14(1):100900. doi: 10.1016/j.tranon.2020.100900. Epub 2020 Oct 21.
3
Carcinogen-induced bladder cancer in the FVB mouse strain is associated with glandular differentiation and increased Cd274/Pdl-1 expression.
致癌物诱导的FVB小鼠品系膀胱癌与腺性分化及Cd274/Pdl-1表达增加有关。
Am J Clin Exp Urol. 2019 Jun 15;7(3):139-152. eCollection 2019.
4
MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK.微小RNA-200c通过直接靶向RECK促进膀胱癌细胞的迁移和侵袭。
Onco Targets Ther. 2016 Aug 16;9:5091-9. doi: 10.2147/OTT.S101067. eCollection 2016.
5
Utility of SAM68 in the progression and prognosis for bladder cancer.SAM68在膀胱癌进展和预后中的作用
BMC Cancer. 2015 May 6;15:364. doi: 10.1186/s12885-015-1367-x.
6
Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.致癌 miRNA-182-5p 靶向作用于人膀胱癌中的 Smad4 和 RECK。
PLoS One. 2012;7(11):e51056. doi: 10.1371/journal.pone.0051056. Epub 2012 Nov 30.
7
Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.抑癌 microRNA-493 通过下调 RhoC 和 FZD4 降低人膀胱癌细胞的运动和迁移能力。
Mol Cancer Ther. 2012 Jan;11(1):244-53. doi: 10.1158/1535-7163.MCT-11-0592. Epub 2011 Nov 4.
8
MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer.MicroRNA-1826 靶向人膀胱癌中的 VEGFC、β-连环蛋白(CTNNB1)和 MEK1(MAP2K1)。
Carcinogenesis. 2012 Jan;33(1):41-8. doi: 10.1093/carcin/bgr239. Epub 2011 Nov 1.
9
Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC).非肌肉浸润性膀胱癌(NMIUC)的分子发生机制。
Expert Rev Mol Med. 2010 Mar 25;12:e10. doi: 10.1017/S1462399410001407.
10
Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma.硫酸乙酰肝素蛋白聚糖-1(CD138)在人尿路上皮癌细胞存活中的作用。
Cancer Sci. 2010 Jan;101(1):155-60. doi: 10.1111/j.1349-7006.2009.01379.x. Epub 2009 Oct 6.